TipRanks
Go Ultimate55% OFF

Inhibrx Biosciences Inc (INBX) Cash flow

Inhibrx Biosciences Inc Cash Flow

INBX's free cash flow for Q2 2026 was $-29.89M. For the 2026 fiscal year, INBX's free cash flow was increased by $27.00K and operating cash flow was $-29.92M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -129.79M$ -194.41M$ -193.31M$ -115.30M$ -80.32M
$ -28.00K$ -2.60M$ -4.59M$ -686.00K$ -809.00K
$ 101.45M$ 71.68M$ 201.96M$ 258.55M$ 83.77M
$ 124.22M$ 152.60M$ 277.92M$ 273.87M$ 131.30M
$ -129.82M$ -197.01M$ -197.90M$ -115.99M$ -81.19M

Currency in USD

Inhibrx Biosciences Inc Cash Flow

-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing